Researchers discover blood biomarker for Lou Gehrig's disease, could lead to new treatments
08:00 EDT 6 Aug 2012 | Medical Xpress
Researchers from Brigham and Women's Hospital (BWH) are the first to discover that changes in monocytes (a type of white blood cell) are a biomarker for amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease. This finding also brings the medica..
Original Article: Researchers discover blood biomarker for Lou Gehrig's disease, could lead to new treatments
More From BioPortfolio on "Researchers discover blood biomarker for Lou Gehrig's disease, could lead to new treatments"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
